JJ Neumiller - Journal of the American Pharmacists Association, 2009 - Am Pharmacists Assoc Type 2 diabetes is characterized by insulin resistance, a ... At A Glance
Synopsis: Incretin-based therapies are a relatively new option for the treatment
of patients with type 2 diabetes. These therapies hold promise in overcom- ... Cited by 4 - Related articles
CME Tracker - Stroke - medscape.com In 2008, however, 3 large, randomized clinical trials designed to establish more
definitively whether intensive glycemic control in diabetes patients reduces
risk of macrovascular complications were published. These trials were ... Related articles
[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …
Y Moritoh, K Takeuchi, M Hazama - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles
JB McGill - jfponline.com Among the treatments available for patients with type 2 diabetes mellitus (T2DM)
who do not achieve or maintain glycemic control with the combination of
lifestyle management and metformin (ie, tier 1/step 1 therapy), 4 other ... Related articles - Cached - All 2 versions
RK Campbell, S Miller - The Diabetes Educator, 2009 - tde.sagepub.com More than 24 million adults and children in the United States are living with
diabetes, and the vast majority of those individuals have type 2 diabetes. The
clinical benefits of good glycemic control have been well established. Most ... Related articles - All 2 versions
G Argyrakopoulou, J Doupis - Advances in Therapy, 2009 - Springer John Doupis ( ) Joslin Diabetes Center, Harvard Medical School, 1 Joslin Place,
Boston, Massachusetts 02215, USA. Email: John.Doupis@joslin.harvard.edu ...
Received: December 22, 2008 / Published online: March 2, 2009 / Printed: ... Related articles - All 2 versions
M Cobble - Gastroenterology, 2007 - jfponline.com Type 2 diabetes (T2D) is characterized by altered glucose homeostasis, including
decreased insulin sensitivity of target tissues, a gradual decline in β-cell
insulin production and secretion, and a progressive inability to suppress ... Related articles - Cached
